A cut-off value of 465 U/mL was recently established to distinguish ILD patients from the healthy subjects and patients with other non-fibrotic lung diseases [7], however the potential value of KL-6 as a biomarker in the differential diagnosis of ILDs is still limited [8,9]. The gene discussed is MUC1; the disease is interstitial lung disease.